Brendan is the former Chief Executive Officer of Deloitte Ireland. He has over 30 years’ national and international experience supporting the growth and development of Deloitte Ireland and advising international clients. Brendan is a qualified chartered accountant and has a Bachelor of Commerce degree from University of Galway. He has completed strategic and executive leadership programmes at the International Institute of Management Development (IMD), Switzerland.
Brendan is currently Chairperson of Glenisk and is on the Boards of Children’s Health Foundation, Galway University Foundation and Business In The Community. He is also a member of the Finance & Resource Committee of University of Galway. Brendan joined the PM Group Board in January 2020 and was appointed Chairperson in July 2021.
Brendan Jennings
Chairman
Brendan is the former Chief Executive Officer of Deloitte Ireland. He has over 30 years’ national and international experience supporting the growth and development of Deloitte Ireland and advising international clients. Brendan is a qualified chartered accountant and has a Bachelor of Commerce degree from University of Galway. He has completed strategic and executive leadership programmes at the International Institute of Management Development (IMD), Switzerland.
Brendan is currently Chairperson of Glenisk and is on the Boards of Children’s Health Foundation, Galway University Foundation and Business In The Community. He is also a member of the Finance & Resource Committee of University of Galway. Brendan joined the PM Group Board in January 2020 and was appointed Chairperson in July 2021.
Rosita is a chartered management accountant and holds a Bachelor of Commerce degree from University College Cork and an MSc in Executive Leadership from University of Ulster. Rosita held a number of senior finance roles in a variety of multinational companies prior to joining PM Group in 2006. With her extensive experience of finance and operations management, Rosita has supported PM Group’s growth and development in a number of finance leadership roles.
Rosita Fennell
Chief Financial Officer
Rosita is a chartered management accountant and holds a Bachelor of Commerce degree from University College Cork and an MSc in Executive Leadership from University of Ulster. Rosita held a number of senior finance roles in a variety of multinational companies prior to joining PM Group in 2006. With her extensive experience of finance and operations management, Rosita has supported PM Group’s growth and development in a number of finance leadership roles.
Anne Böcker is an independent, non-executive director and chairperson of the Audit Risk & Finance Committee of the Board. Anne retired from PwC Germany following 24 years as partner in audit and risk management. She brings extensive international experience working with national and multi-national organisations in the pharmaceutical and chemical industries. Anne holds a Masters of Business Administration from Universität Münster. She was appointed to the PM Group Board in July 2024.
Anne Böcker
Non-Executive Director
Anne Böcker is an independent, non-executive director and chairperson of the Audit Risk & Finance Committee of the Board. Anne retired from PwC Germany following 24 years as partner in audit and risk management. She brings extensive international experience working with national and multi-national organisations in the pharmaceutical and chemical industries. Anne holds a Masters of Business Administration from Universität Münster. She was appointed to the PM Group Board in July 2024.
Andy is the Group’s Executive Director for pharma and Chief Technology Officer. He has been with PM Group since 1989 and has over 30 years’ experience working with leading global pharma companies on projects all over the world. He is a leading international expert in the design of pharmaceutical manufacturing facilities. He is a Chemical Engineer and a Fellow of IChemE and also holds a Masters Degree in Executive Leadership. Andy joined the PM Group Board in 2018.
Andy Rayner
Executive Director
Andy is the Group’s Executive Director for pharma and Chief Technology Officer. He has been with PM Group since 1989 and has over 30 years’ experience working with leading global pharma companies on projects all over the world. He is a leading international expert in the design of pharmaceutical manufacturing facilities. He is a Chemical Engineer and a Fellow of IChemE and also holds a Masters Degree in Executive Leadership. Andy joined the PM Group Board in 2018.
Helen is the former Chief Executive Officer of Creganna Medical. She has over 25 years’ experience in the Medical Device industry with previous roles in product development/research at Medtronic and Tyco Healthcare (Covidien). Helen is an adviser with Enterprise Ireland. She has a Bachelor of Engineering (Civil) from NUI Galway, a Masters in Project Management from UL, an honorary Doctorate from NUIG, and a Life Fellowship from the Irish Management Institute. She is a Fellow of the Institute of Engineers of Ireland. Helen joined the PM Group Board in January 2020.
Helen Ryan
Non-Executive Director
Helen is the former Chief Executive Officer of Creganna Medical. She has over 25 years’ experience in the Medical Device industry with previous roles in product development/research at Medtronic and Tyco Healthcare (Covidien). Helen is an adviser with Enterprise Ireland. She has a Bachelor of Engineering (Civil) from NUI Galway, a Masters in Project Management from UL, an honorary Doctorate from NUIG, and a Life Fellowship from the Irish Management Institute. She is a Fellow of the Institute of Engineers of Ireland. Helen joined the PM Group Board in January 2020.